Debt-to-equity in % of Iterum Therapeutics plc from Q1 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Iterum Therapeutics plc quarterly Debt-to-equity history and change rate from Q1 2019 to Q3 2025.
  • Iterum Therapeutics plc Debt-to-equity for the quarter ending 30 Sep 2025 was -905 %, a 185% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Iterum Therapeutics plc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -905 -588 -185% 30 Sep 2025
Q2 2025 -679 -80.7 -13.5% 30 Jun 2025
Q1 2025 -471 +6.49K +93.2% 31 Mar 2025
Q4 2024 -389 -1.05K -159% 31 Dec 2024
Q3 2024 -317 -592 -215% 30 Sep 2024
Q2 2024 -598 -784 -422% 30 Jun 2024
Q1 2024 -6.96K -7.08K -5832% 31 Mar 2024
Q4 2023 658 +562 +589% 31 Dec 2023
Q3 2023 275 +190 +225% 30 Sep 2023
Q2 2023 186 +106 +133% 30 Jun 2023
Q1 2023 121 +30 +32.8% 31 Mar 2023
Q4 2022 95.4 -31.2 -24.7% 31 Dec 2022
Q3 2022 84.7 -253 -74.9% 30 Sep 2022
Q2 2022 79.7 +1.19K 30 Jun 2022
Q1 2022 91.4 +358 31 Mar 2022
Q4 2021 127 +294 31 Dec 2021
Q3 2021 337 +510 30 Sep 2021
Q2 2021 -1.11K -884 -392% 30 Jun 2021
Q1 2021 -266 +243 +47.7% 31 Mar 2021
Q4 2020 -168 -573 -141% 31 Dec 2020
Q3 2020 -173 -287 -252% 30 Sep 2020
Q2 2020 -226 -281 -510% 30 Jun 2020
Q1 2020 -509 -543 -1608% 31 Mar 2020
Q4 2019 406 31 Dec 2019
Q3 2019 114 30 Sep 2019
Q2 2019 55.1 30 Jun 2019
Q1 2019 33.8 31 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.